Lymph vessel growth, also known as lymphangiogenesis, is crucial during development, wound healing, inflammation and tumour metastasis. To enable non-invasive detection and quantification of lymphangiogenesis, Martínez-Corral et al. developed a mouse model expressing an enhanced green fluorescent (EGFP)-luciferase (Luc) fusion protein under the control of endogenous VegfR3 (encoding vascular endothelial growth factor receptor 3, a lymphatic marker). VegfR3EGFPLucknock-in mice were used to visualise lymphangiogenesis during development and postnatally, when VegfR3 expression is downregulated. Additionally, growth-factor-stimulated lymphangiogenesis was visualised in live, adult mice using VEGF-C, which resulted in an eightfold increase in Luc signal compared with control mice. The authors also validated their model by visualising lymphangiogenesis during wound healing and inflammation. Finally, they demonstrated that their model is suitable for visualising tumour-induced lymph vessel growth. These mice provide a novel and highly sensitive tool to study the involvement of lymphangiogenesis in normal development and various pathological conditions.
Visualising lymphangiogenesis in vivo Open Access
Visualising lymphangiogenesis in vivo. Dis Model Mech 1 May 2012; 5 (3): 287. doi:
Download citation file:
Advertisement
Cited by
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and Sadaf Farooqi, and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
Other journals from
The Company of Biologists